p27(Kip1) alters the response of cells to mitogen and is part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation

Current Biology

Volumn 8, Issue 8, 1998, Pages 431-440

  Durand, Béatrice ^a,c   Fero, Matthew L ^b   Roberts, James M ^b   Raff, Martin C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Fred Hutchinson Cancer Research Center   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CDKN1B PROTEIN, MOUSE; CELL CYCLE PROTEIN; CHONDROITIN SULFATE PROTEOGLYCAN 4; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MICROTUBULE ASSOCIATED PROTEIN; MITOGENIC AGENT; PLATELET DERIVED GROWTH FACTOR; PROTEOGLYCAN; THYROID HORMONE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; ARTICLE; BIOLOGICAL RHYTHM; CELL CLONE; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CROSS BREEDING; CYTOLOGY; GENETICS; GENOTYPE; MOUSE; MOUSE MUTANT; OLIGODENDROGLIA; OPTIC NERVE; PHYSIOLOGY;

ANIMALS; ANTIGENS; BIOLOGICAL CLOCKS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CELLS, CULTURED; CLONE CELLS; CROSSES, GENETIC; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENOTYPE; MICE; MICE, MUTANT STRAINS; MICROTUBULE-ASSOCIATED PROTEINS; MITOGENS; OLIGODENDROGLIA; OPTIC NERVE; PLATELET-DERIVED GROWTH FACTOR; PROTEOGLYCANS; THYROID HORMONES; TUMOR SUPPRESSOR PROTEINS;

EID: 0032498961     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(98)70177-0     Document Type: Article

References (55)

1. Raff M: Size control: the regulation of cell numbers in animal development. Cell 1996, 86:173-175.
2. Barres B, Raff M: Control of oligodendrocyte number in the developing rat optic nerve. Neuron 1994, 12:935-942.
3. Small R, Riddle P, Noble M: Evidence for migration of oligodendrocyte-type-2 astrocyte progenitor cells into the developing rat optic nerve. Nature 1987, 328:155-157.
4. Temple S, Raff M: Clonal analysis of oligodendrocyte development in culture: evidence for a developmental clock that counts cell divisions. Cell 1986, 44:773-779.
5. Barres B, Hart I, Coles H, Burne J, Voyvodic J, Richardson W, Raff M: Cell death and control of cell survival in the oligodendrocyte lineage. Cell 1992, 70:31-46.
6. Barres B, Lazar M, Raff M: A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 1994, 120:1097-1108.
7. Gao F-B, Durand B, Raff M: Oligodendrocyte precursor cells count time but not cell divisions before differentiation. Curr Biol 1997, 7:152-155.
8. Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M: A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 1988, 53:309-319.
9. Noble M, Murray K: Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell. EMBO J 1984, 3:2243-2247.
10. Raff M: Glial cell diversification in the rat optic nerve. Science 1989, 243:1450-1455.
11. Bögler O, Noble M: Measurement of time in oligodendrocyte-type 2 astrocyte (O-2A) progenitors is a cellular process distinct from differentiation or division. Dev Biol 1994, 162:525-538.
12. Lees E: Cyclin dependent kinase regulation. Curr Opin Cell Biol 1995, 7:773-780.
13. Morgan D: Principles of CDK regulation. Nature 1995, 374:131-134.
14. Sherr C: G1 phase progression: cycling on cue. Cell 1994, 79:551-556.
15. Sherr C, Roberts J: Inhibitors of mammalian G1 cyclin dependent kinases. Genes Dev 1995, 9:1149-1163.
16. Harper W, Elledge S: Cdk inhibitors in development and cancer. Curr Opin Genet Dev 1996, 6:56-64.
17. Matsuoka S, Edwards M, Bai C, Parker S, Zhang P, Baldini A, et al.: p57 Kip2, a structurally distinct member of the p21 Cip1 inhibitor family, is a candidate tumor suppressor gene. Genes Dev 1995, 9:650-662.
18. Parker S, Eichele G, Zhang P, Rawls A, Sands A, Bradley A, et al.: p53-independent expression of p21 Cip1 in muscle and other terminally differentiating cells. Science 1995, 267:1024-1027.
19. Durand B, Gao F-B, Raff M: Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J 1997, 16:306-317.
20. Fero M, Rivkin M, Tasch M, Porter P, Carow C, Firpo E, et al.: A syndrome of multi-organ hyperplasia with features of gigantism, tumorigenesis and female sterility in p27Kip1 -deficient mice. Cell 1996, 85:733-744.
21. Kiyokawa H, Kineman R, Manova-Todorova K, Scares V, Hollman E, Ono M, et al.: Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1. Cell 1996, 85:721-732.
22. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, et al.: Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia and pituary tumors. Cell 1996, 85:707-720.
23. Casaccia-Bonnefil P, Tikoo R, Kiyokawa H, Friedrich VJ, Chao MV, Koff A: Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27/Kip1. Genes Dev 1997, 11:2335-2346.
24. Raff MC, Mirsky R, Fields KL, Lisak RP, Dorfman SH, Silberberg DH, et al.: Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature 1978, 274:813-816.
25. Raff MC, Miller RH, Noble M: A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 1983, 303:390-396.
26. Ranscht B, Clapshaw P, Price J, Noble M, Seifert W: Development of oligodendrocytes and schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci USA 1982, 79:2709-2713.
27. Eisenbarth GS, Walsh FS, Nirenberg M: Monoclonal antibody to a plasma membrane antigen of neurons. Proc Natl Acad Sci USA 1979, 76:4913-4917.
28. Fanarraga M, Sommer I, Griffiths I: O-2A progenitors of the mouse optic nerve exhibit a developmental pattern of antigen expression different from the rat. Glia 1995, 15:95-104.
29. Stallcup W, Beasley L: Potential glial precursor cells of the optic nerve express the NG2 proteoglycan. J Neurosci 1987, 7:2737-2744.
30. Gao F-B, Apperly J, Raff M: Cell size control and a cell-intrinsic maturation program in proliferating oligodendrocyte precursor cells. J Cell Biol 1997, 138:1367-1377.
31. Raff M, Lillien L, Richardson W, Burnem J, Noble M: Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 1988, 333:562-565.
32. Barres B, Schmid R, Sendtner M, Raff M: Multiple extracellular signals are required for long term oligodendrocyte survival. Development 1993, 118:283-295.
33. Lane M, Sauer K, Wallace K, Jan Y-N, Lehner C, Vaessin H: Dacapo, a cyclin-dependent kinase inhibitor stops cell proliferation during Drosophila development. Cell 1996, 87:1225-1235.
34. de Nooij J, Letendre M, Hariharan I: A cyclin-dependent kinase inhibitor, Dacapo, is necessary for timely exit from the cell cycle during Drosophila embryogenesis. Cell 1996, 87:1237-1247.
35. Knoblich J, Sauer K, Jones L, Richardson H, Saint R, Lehner C: Cyclin E controls S phase progression and its down regulation during Drosophila embryogenesis is required for the arrest of cell proliferation. Cell 1994, 77:107-120.
36. Coats S, Flanagan W, Nourse J, Roberts J: Requirement of p27/Kip1 for restriction point control of the fibroblast cell cycle. Science 1996, 272:877-880.
37. Perez-Roger I, Solomon DL, Sewing A, Land H: Myc activation of cyclinE/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene 1997, 14:2373-2381.
38. Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B: Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J 1996, 15:6595-6604.
39. Hengst L, Reed S: Translational control of p27Kip1 accumulation during the cell cycle. Science 1996, 271:1861-1864.
40. Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE: Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev 1997, 11:1464-1478.
41. Winston J, Dong F, Pledger WJ: Differential modulation of G1 cyclins and the Cdk inhibitor p27kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts. J Biol Chem 1996, 271:11253-11260.
42. Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR: Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 1997, 387:422-426.
43. Millard SS, Yan JS, Nguyen H, Pagano M, Kiyokawa H, Koff A: Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest. J Biol Chem 1997, 272:7093-7098.
44. Grove EA, Williams BP, Li DQ, Hajihosseimi M, Friedrich A, Price J: Multiple restricted lineages in the embryonic rat cerebral cortex. Development 1993, 117:553-561.
45. Firpo E, Koff A, Solomon M, Roberts J: Inactivation of a cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol Cell Biol 1994, 14:4889-4901.
46. Kato J-Y, Matsuoka M, Polyak K, Massagué J, Sherr C: Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27 Kip1) of cyclin-dependent kinase 4 activation. Cell 1994, 79:487-496.
47. Nourse J, Firpo E, Flanagan W, Coats S, Polyak K, Lee M, et al.: Interleukin-2-mediated elimination of the p27Kip1 cyclin dependent kinase inhibitor prevented by rapamycin. Nature 1994, 372:570-573.
48. Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts J, Tempst P, Massagué J: Cloning of p27 Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994, 78:59-66.
49. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 1994, 78:67-74.
50. Pagano M, Tam S, Theodoras A, Beer-Romero P, Del Sal G, Chau V, et al.: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995, 269:682-685.
51. Bottenstein J, Sato G: Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 1979, 76:514-517.
52. Lillien L, Raff M: Differentiation signals in the CNS: type-2 astrocyte development in vitro as a model system. Neuron 1990, 5:111-119.
53. Lillien LE, Sendtner M, Rohrer H, Hughes SM, Raff MC: Type-2 astrocyte development in rat brain cultures is initiated by a CNTF-like protein produced by type-1 astrocytes. Neuron 1988, 1:485-494.
54. Neophytou C, Vernallis AB, Smith A, Raff MC: Müller-cell-derived leukaemia inhibitory factor arrests rod photoreceptor differentiation at a postmitotic pre-rodstage of development. Development 1997, 124:2345-2354.
55. Magaud J, Sargent I, Mason D: Detection of human white cell proliferative responses by immunoenzymatic measurement of bromodeoxyuridine uptake. J Immunol Methods 1988, 106:95-100.